Zymergen investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of zymergen - zy

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of zymergen inc. (nasdaqgs: zy) to ginkgo bioworks holdings, inc. (nyse: dna). under the terms of the proposed transaction, shareholders of zymergen will receive a fixed exchange ratio of 0.9179 ginkgo shares for each share of zymergen that they own. ksf is seeking to determine whether this consideration and the
DNA Ratings Summary
DNA Quant Ranking